Our ever-expanding team!
We have appointed Rodrigo Cervantes as Commercial Director, bringing years of experience in diagnostics and the Latin American market to GlowDx.
Rodrigo joins GlowDx to lead its commercial operations, with a focus on building the molecular diagnostics market in emerging markets through GlowDx’s molecular diagnostic assays menu and molecular Point-of-Care platform. Rodrigo will be a member of the GlowDx executive management and be responsible for the commercial development of GlowDx’s infectious disease molecular diagnostic products.
Rodrigo joins GlowDx with substantial experience in both oncology and infectious disease healthcare markets. At Leica Biosystems, a Danaher company (NYSE: DHR), Rodrigo has been General Manager for LATAM and Brazil, Responsible for Sales and Operations in Latin America, based in Sao Paulo. Prior to this, he was marketing & sales director of Mexico and Central America for Abbott Diagnostics, also holding senior commercial roles with Fresenius Medical Care, Baxter and Johnson&Johnson.